237 related articles for article (PubMed ID: 26454081)
1. Blockade of metabotropic glutamate receptor 5 protects against DNA damage in a rotenone-induced Parkinson's disease model.
Xia N; Zhang Q; Wang ST; Gu L; Yang HM; Liu L; Bakshi R; Yang H; Zhang H
Free Radic Biol Med; 2015 Dec; 89():567-80. PubMed ID: 26454081
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of metabotropic glutamate receptor 5 inhibits hepatoma development in a neurotoxin rotenone-induced Parkinson's disease model.
Bai XX; Gu L; Yang HM; Xi SS; Xia N; Zhang S; Zhang H
Toxicol Lett; 2018 May; 288():71-81. PubMed ID: 29458170
[TBL] [Abstract][Full Text] [Related]
3. Selective blockade of mGlu5 metabotropic glutamate receptors is protective against hepatic mitochondrial dysfunction in 6-OHDA lesioned Parkinsonian rats.
Ferrigno A; Vairetti M; Ambrosi G; Rizzo V; Richelmi P; Blandini F; Fuzzati-Armentero MT
Clin Exp Pharmacol Physiol; 2015 Jun; 42(6):695-703. PubMed ID: 25904005
[TBL] [Abstract][Full Text] [Related]
4. PDZ Scaffold Protein CAL Couples with Metabotropic Glutamate Receptor 5 to Protect Against Cell Apoptosis and Is a Potential Target in the Treatment of Parkinson's Disease.
Luo WY; Xing SQ; Zhu P; Zhang CG; Yang HM; Van Halm-Lutterodt N; Gu L; Zhang H
Neurotherapeutics; 2019 Jul; 16(3):761-783. PubMed ID: 31073978
[TBL] [Abstract][Full Text] [Related]
5. Blockade of metabotropic glutamate receptor 5 attenuates axonal degeneration in 6-hydroxydopamine-induced model of Parkinson's disease.
Zhang JN; Huang YL; Yang HM; Wang Y; Gu L; Zhang H
Mol Cell Neurosci; 2021 Jan; 110():103572. PubMed ID: 33248235
[TBL] [Abstract][Full Text] [Related]
6. Upregulated mGluR5 induces ER stress and DNA damage by regulating the NMDA receptor subunit NR2B.
Gu L; Luo WY; Xia N; Zhang JN; Fan JK; Yang HM; Wang MC; Zhang H
J Biochem; 2022 Mar; 171(3):349-359. PubMed ID: 34908130
[TBL] [Abstract][Full Text] [Related]
7. Metabotropic glutamate receptor 5 mediates the suppressive effect of 6-OHDA-induced model of Parkinson's disease on liver cancer.
Xi SS; Bai XX; Gu L; Bao LH; Yang HM; An W; Wang XM; Zhang H
Pharmacol Res; 2017 Jul; 121():145-157. PubMed ID: 28455267
[TBL] [Abstract][Full Text] [Related]
8. Extracellular cysteine (Cys)/cystine (CySS) redox regulates metabotropic glutamate receptor 5 activity.
Zhu JW; Yuan JF; Yang HM; Wang ST; Zhang CG; Sun LL; Yang H; Zhang H
Biochimie; 2012 Mar; 94(3):617-27. PubMed ID: 21964032
[TBL] [Abstract][Full Text] [Related]
9. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
Verma R; Nehru B
Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
[TBL] [Abstract][Full Text] [Related]
10. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of asiatic acid on rotenone-induced mitochondrial dysfunction and oxidative stress-mediated apoptosis in differentiated SH-SYS5Y cells.
Nataraj J; Manivasagam T; Justin Thenmozhi A; Essa MM
Nutr Neurosci; 2017 Jul; 20(6):351-359. PubMed ID: 26856988
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of candesartan cilexitil in the rotenone rat model of Parkinson's disease.
Wu L; Tian YY; Shi JP; Xie W; Shi JQ; Lu J; Zhang YD
Neurosci Lett; 2013 Aug; 548():50-5. PubMed ID: 23774475
[TBL] [Abstract][Full Text] [Related]
13. Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
Alam M; Danysz W; Schmidt WJ; Dekundy A
Toxicol Appl Pharmacol; 2009 Oct; 240(2):198-207. PubMed ID: 19616571
[TBL] [Abstract][Full Text] [Related]
14. Rotenone-induced parkinsonism elicits behavioral impairments and differential expression of parkin, heat shock proteins and caspases in the rat.
Sonia Angeline M; Chaterjee P; Anand K; Ambasta RK; Kumar P
Neuroscience; 2012 Sep; 220():291-301. PubMed ID: 22710069
[TBL] [Abstract][Full Text] [Related]
15. Lowered iPLA
Chao H; Liu Y; Fu X; Xu X; Bao Z; Lin C; Li Z; Liu Y; Wang X; You Y; Liu N; Ji J
Exp Neurol; 2018 Feb; 300():74-86. PubMed ID: 29104115
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of metabotropic glutamate receptor 5 induces cellular stress through pertussis toxin-sensitive Gi-proteins in murine BV-2 microglia cells.
Chantong B; Kratschmar DV; Lister A; Odermatt A
J Neuroinflammation; 2014 Nov; 11():190. PubMed ID: 25407356
[TBL] [Abstract][Full Text] [Related]
17. Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats.
Karuppagounder SS; Madathil SK; Pandey M; Haobam R; Rajamma U; Mohanakumar KP
Neuroscience; 2013 Apr; 236():136-48. PubMed ID: 23357119
[TBL] [Abstract][Full Text] [Related]
18. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
Takeuchi H; Yanagida T; Inden M; Takata K; Kitamura Y; Yamakawa K; Sawada H; Izumi Y; Yamamoto N; Kihara T; Uemura K; Inoue H; Taniguchi T; Akaike A; Takahashi R; Shimohama S
J Neurosci Res; 2009 Feb; 87(2):576-85. PubMed ID: 18803299
[TBL] [Abstract][Full Text] [Related]
19. Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats.
Lin CH; Huang JY; Ching CH; Chuang JI
J Pineal Res; 2008 Mar; 44(2):205-13. PubMed ID: 18289173
[TBL] [Abstract][Full Text] [Related]
20. Role of metabotropic glutamate receptors in the mechanisms of experimental parkinsonism development.
Bashkatova VG; Sudakov SK
Bull Exp Biol Med; 2012 Sep; 153(5):655-7. PubMed ID: 23113249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]